换一批BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T-cell lymphoblastic lymphoma.
第一作者：
Xiao-Peng,Tian
第一单位：
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, P. R. China.;Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, P. R. China.
作者：
医学主题词
成年人(Adult);DNA结合蛋白质类(DNA-Binding Proteins);抗药性, 肿瘤(Drug Resistance, Neoplasm);细胞外信号调节MAP激酶类(Extracellular Signal-Regulated MAP Kinases);女(雌)性(Female);鸟嘌呤核苷酸交换因子类(Guanine Nucleotide Exchange Factors);人类(Humans);男(雄)性(Male);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);信号传导(Signal Transduction);转录因子(Transcription Factors);ras蛋白质类(ras Proteins)
DOI
10.1002/cac2.12039
PMID
32459053
发布时间
2026-01-27
- 浏览2
Cancer communications (London, England)
2020年40卷6期
245-259页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
